Charalambous, Lefko T.
Adil, Syed M.
Rajkumar, Shashank
Gramer, Robert
Kirsch, Elayna
Liu, Beiyu
Zomorodi, Ali
McClellan, Mark
Lad, Shivanand P.
Funding for this research was provided by:
National Center for Advancing Translational Sciences (UL1TR002553)
Article History
Received: 23 November 2021
Revised: 21 June 2022
Accepted: 13 July 2022
First Online: 26 July 2022
Declarations
:
: This study was declared exempt from Institutional Review Board approval as it does not report private health information.
: SPL is a consultant for Abbott, Boston Scientific, Higgs Boson Health, Medtronic, Minnetronix, Nevro, and Presidio Medical. SMA and LTC are consultants for Higgs Boson Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. All other authors report no conflicts of interest.